BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 12297843)

  • 1. Albumin dialysis in cirrhosis with superimposed acute liver injury: a prospective, controlled study.
    Heemann U; Treichel U; Loock J; Philipp T; Gerken G; Malago M; Klammt S; Loehr M; Liebe S; Mitzner S; Schmidt R; Stange J
    Hepatology; 2002 Oct; 36(4 Pt 1):949-58. PubMed ID: 12297843
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improvement of impaired albumin binding capacity in acute-on-chronic liver failure by albumin dialysis.
    Klammt S; Mitzner SR; Stange J; Loock J; Heemann U; Emmrich J; Reisinger EC; Schmidt R
    Liver Transpl; 2008 Sep; 14(9):1333-9. PubMed ID: 18756471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized controlled study of extracorporeal albumin dialysis for hepatic encephalopathy in advanced cirrhosis.
    Hassanein TI; Tofteng F; Brown RS; McGuire B; Lynch P; Mehta R; Larsen FS; Gornbein J; Stange J; Blei AT
    Hepatology; 2007 Dec; 46(6):1853-62. PubMed ID: 17975845
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extracorporeal albumin dialysis: a procedure for prolonged relief of intractable pruritus in patients with primary biliary cirrhosis.
    Parés A; Cisneros L; Salmerón JM; Caballería L; Mas A; Torras A; Rodés J
    Am J Gastroenterol; 2004 Jun; 99(6):1105-10. PubMed ID: 15180733
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improvement of hepatorenal syndrome with extracorporeal albumin dialysis MARS: results of a prospective, randomized, controlled clinical trial.
    Mitzner SR; Stange J; Klammt S; Risler T; Erley CM; Bader BD; Berger ED; Lauchart W; Peszynski P; Freytag J; Hickstein H; Loock J; Löhr JM; Liebe S; Emmrich J; Korten G; Schmidt R
    Liver Transpl; 2000 May; 6(3):277-86. PubMed ID: 10827226
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extracorporeal albumin dialysis with the molecular adsorbent recirculating system in acute-on-chronic liver failure: the RELIEF trial.
    Bañares R; Nevens F; Larsen FS; Jalan R; Albillos A; Dollinger M; Saliba F; Sauerbruch T; Klammt S; Ockenga J; Pares A; Wendon J; Brünnler T; Kramer L; Mathurin P; de la Mata M; Gasbarrini A; Müllhaupt B; Wilmer A; Laleman W; Eefsen M; Sen S; Zipprich A; Tenorio T; Pavesi M; Schmidt HH; Mitzner S; Williams R; Arroyo V;
    Hepatology; 2013 Mar; 57(3):1153-62. PubMed ID: 23213075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Efficiency of dialysis with albumin in the treatment of patients with advanced hepatic insufficiency: initial experience with the MARS system in Spain].
    Avilés J; Macía M; Morales S; Pérez F; Moreno A; Navarro J; Navazo L; García J
    Nefrologia; 2001; 21(4):376-85. PubMed ID: 11816514
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preconditioning by extracorporeal liver support (MARS) of patients with cirrhosis and severe liver failure evaluated for living donor liver transplantation -- a pilot study.
    Choi JY; Bae SH; Yoon SK; Cho SH; Yang JM; Han JY; Ahn BM; Chung KW; Sun HS; Kim DG
    Liver Int; 2005 Aug; 25(4):740-5. PubMed ID: 15998424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute decompensation and absence of brain and kidney dysfunction predict long-term efficacy of plasma exchange in hyper-bilirubinemic cirrhotic patients awaiting liver transplantation.
    Annicchiarico BE; Avolio AW; Siciliano M; Passalacqua S; Caracciolo G; Gasbarrini A; Agnes S; Castagneto M
    Transplant Proc; 2008; 40(6):1929-31. PubMed ID: 18675092
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extracorporeal albumin dialysis.
    Abe T; Shono M; Kodama T; Kita Y; Fukagawa M; Akizawa T
    Ther Apher Dial; 2004 Jun; 8(3):217-22. PubMed ID: 15154874
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Performance of the hepatic encephalopathy scoring algorithm in a clinical trial of patients with cirrhosis and severe hepatic encephalopathy.
    Hassanein T; Blei AT; Perry W; Hilsabeck R; Stange J; Larsen FS; Brown RS; Caldwell S; McGuire B; Nevens F; Fontana R
    Am J Gastroenterol; 2009 Jun; 104(6):1392-400. PubMed ID: 19455117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modification of continuous venovenous hemodiafiltration with single-pass albumin dialysate allows for removal of serum bilirubin.
    Chawla LS; Georgescu F; Abell B; Seneff MG; Kimmel PL
    Am J Kidney Dis; 2005 Mar; 45(3):e51-6. PubMed ID: 15754264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Tuberculosis in compromised hosts].
    Kekkaku; 2003 Nov; 78(11):717-22. PubMed ID: 14672050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effective bilirubin reduction by single-pass albumin dialysis in liver failure.
    Boonsrirat U; Tiranathanagul K; Srisawat N; Susantitaphong P; Komolmit P; Praditpornsilpa K; Tungsanga K; Eiam-Ong S
    Artif Organs; 2009 Aug; 33(8):648-53. PubMed ID: 19624591
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of on-line high-flux hemofiltration versus low-flux hemodialysis on mortality in chronic kidney failure: a small randomized controlled trial.
    Santoro A; Mancini E; Bolzani R; Boggi R; Cagnoli L; Francioso A; Fusaroli M; Piazza V; Rapanà R; Strippoli GF
    Am J Kidney Dis; 2008 Sep; 52(3):507-18. PubMed ID: 18617304
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Results of a phase I trial evaluating a liver support device utilizing albumin dialysis.
    Awad SS; Swaniker F; Magee J; Punch J; Bartlett RH
    Surgery; 2001 Aug; 130(2):354-62. PubMed ID: 11490371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Charcoal-based hemodiabsorption liver support for episodic type C hepatic encephalopathy.
    Hill K; Hu KQ; Cottrell A; Teichman S; Hillebrand DJ
    Am J Gastroenterol; 2003 Dec; 98(12):2763-70. PubMed ID: 14687830
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of the molecular adsorbent recirculating system and Prometheus devices on systemic haemodynamics and vasoactive agents in patients with acute-on-chronic alcoholic liver failure.
    Laleman W; Wilmer A; Evenepoel P; Elst IV; Zeegers M; Zaman Z; Verslype C; Fevery J; Nevens F
    Crit Care; 2006; 10(4):R108. PubMed ID: 16859530
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transjugular intrahepatic portosystemic shunting versus paracentesis plus albumin for refractory ascites in cirrhosis.
    Ginès P; Uriz J; Calahorra B; Garcia-Tsao G; Kamath PS; Del Arbol LR; Planas R; Bosch J; Arroyo V; Rodés J
    Gastroenterology; 2002 Dec; 123(6):1839-47. PubMed ID: 12454841
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Terlipressin and albumin vs albumin in patients with cirrhosis and hepatorenal syndrome: a randomized study.
    Martín-Llahí M; Pépin MN; Guevara M; Díaz F; Torre A; Monescillo A; Soriano G; Terra C; Fábrega E; Arroyo V; Rodés J; Ginès P;
    Gastroenterology; 2008 May; 134(5):1352-9. PubMed ID: 18471512
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.